TGTX ▼ -0.7% - TG Therapeutics, Inc.
$TGTX - TG Therapeutics Announces Publication of Five-Year Comparative Analysis of BRIUMVI Versus Ocrelizumab and Ofatumumab in Relapsing Multiple Sclerosis
12-OCT-2026 07:33 AM ET
Share this post
More filings for $TGTX
TGTX - TG Therapeutics, Inc. - SEC Filing Update (27-OCT-2026) | ThinkSabio - Stocks SimplifiedOct 27, 2026TGTX ▼ -1.5% - TG Therapeutics, Inc.Oct 23, 2026TGTX ▼ -1.5% - TG Therapeutics, Inc.Oct 23, 2026TGTX ▲ +0.5% - TG Therapeutics, Inc.Oct 21, 2026TGTX ▼ -0.1% - TG Therapeutics, Inc.Oct 21, 2026TGTX ▼ -0.7% - TG Therapeutics, Inc.Oct 12, 2026
View full $TGTX filing history →💬 Comments
Loading comments…
Leave a comment